Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India. Hyderabad-based pharmaceutical and
Read MoreStreptococcus pneumonia infection remains one of the leading causes of death among children under five in India. Hyderabad-based pharmaceutical and
Read MoreBiological E., will run a clinical trial of Providence’s vaccine in India and seek emergency use approval for it, the
Read More